Michelle Elizabeth Hung

Title: Michelle Elizabeth Hung: Innovator in Chimeric Receptor Technology

Introduction

Michelle Elizabeth Hung is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biomedical engineering, particularly in the development of chimeric receptors for cancer treatment. Her innovative work focuses on addressing acute myeloid leukemia, a challenging form of cancer.

Latest Patents

Michelle holds a patent for "Chimeric receptors and methods of use thereof." This patent outlines acute myeloid leukemia antigen targets for chimeric receptors and methods of using them. Her groundbreaking research aims to improve therapeutic strategies for patients suffering from this aggressive disease. She has 1 patent to her name.

Career Highlights

Michelle is currently employed at Senti Biosciences, Inc., where she continues to advance her research in the field of synthetic biology and cancer therapies. Her work at Senti Biosciences has positioned her as a key player in the development of innovative treatments that harness the power of the immune system.

Collaborations

Michelle collaborates with talented professionals in her field, including Brian Scott Garrison and Jennifer Chien. These partnerships enhance her research efforts and contribute to the advancement of chimeric receptor technology.

Conclusion

Michelle Elizabeth Hung is a trailblazer in the field of chimeric receptor technology, with a focus on improving treatments for acute myeloid leukemia. Her contributions to the scientific community are paving the way for future innovations in cancer therapy.